DTC/DTP + Telemedicine – The Next Big Thing in Pharma?
How should pharma leaders adapt to this new DTC/DTP-driven world, and what role does telemedicine play in closing the loop from awareness to access?
DTC/DTP + Telemedicine: The Next Big Thing in Pharma?
Archbow Consulting recently partnered with Omnicom Health to raise awareness about a buzz-worthy case study examining the recent trend of Direct-to-Consumer (DTC) and Direct-to-Patient (DTP) models—and what these shifts mean for the future of the pharmaceutical industry.
Discover how DTC/DTP and telemedicine are transforming healthcare access. Dive into real-world insights on digital health solutions, improved patient outcomes, and the evolving landscape of care delivery. Read the full case study here.
For additional insights on this topic, you may also enjoy the following:
Thinking Beyond the One-Size-Fits-All Approach: Choosing the Ideal 3PL Partnership
Today’s 3PL landscape offers more specialized distribution solutions than ever before. Learn how manufacturers can evaluate third-party logistics providers, align capabilities to product needs, and make informed 3PL partner decisions for a successful pharmaceutical product launch.
No Patient Left Behind: Mastering Specialty Pharmacy Network Transitions
Specialty Pharmacy (SP) networks are not static. As manufacturers evaluate performance, access, and partner capabilities, network changes may become necessary.
Staffing Your Patient Support Program: The Right Sizing Formula for Modern Operations
Learn how to right-size patient support program staffing with data-driven models that balance efficiency, cost, service quality, and patient experience.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|